Total Payments
$4,596
2024 Payments
$1,532
Companies
56
Transactions
256
Medicare Patients
4,288
Medicare Billing
$795,076

Payment Breakdown by Category

Food & Beverage$4,415 (96.1%)
Education$180.99 (3.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,415 254 96.1%
Education $180.99 2 3.9%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $454.54 32 $0 (2024)
Merck Sharp & Dohme LLC $374.49 23 $0 (2024)
PFIZER INC. $280.51 16 $0 (2024)
Seagen Inc. $255.80 12 $0 (2023)
Janssen Biotech, Inc. $223.23 15 $0 (2024)
Novocure Inc. $204.21 12 $0 (2024)
Amgen Inc. $183.91 8 $0 (2022)
AstraZeneca Pharmaceuticals LP $178.58 9 $0 (2024)
Daiichi Sankyo Inc. $177.48 10 $0 (2024)
Tempus AI, Inc $141.51 5 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,532 87 Novartis Pharmaceuticals Corporation ($251.46)
2023 $1,228 69 Merck Sharp & Dohme LLC ($130.85)
2022 $1,277 69 Amgen Inc. ($183.91)
2021 $133.99 9 Janssen Biotech, Inc. ($36.95)
2020 $82.56 1 Boston Scientific Corporation ($82.56)
2019 $95.18 6 Janssen Biotech, Inc. ($26.22)
2018 $174.40 10 Novocure Inc. ($63.98)
2017 $72.30 5 INSYS Therapeutics Inc ($34.08)

All Payment Transactions

256 individual payment records from CMS Open Payments — Page 1 of 11

Date Company Product Nature Form Amount Type
12/18/2024 Janssen Biotech, Inc. ERLEADA (Drug), AKEEGA Food and Beverage In-kind items and services $19.15 General
Category: Oncology
12/16/2024 Rigel Pharmaceuticals, Inc. Rezlidhia (Drug), Tavalisse Food and Beverage Cash or cash equivalent $13.07 General
Category: Acute Myeloid Leukemia
12/13/2024 Genentech USA, Inc. Tecentriq (Biological), Tecentriq Hybreza Food and Beverage In-kind items and services $13.83 General
Category: BioOncology
12/10/2024 TerSera Therapeutics LLC Zoladex (Drug) Food and Beverage In-kind items and services $13.74 General
Category: Oncology
12/05/2024 Tempus AI, Inc Food and Beverage In-kind items and services $24.44 General
12/02/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $19.71 General
Category: ONCOLOGY
11/26/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), LYNPARZA Food and Beverage In-kind items and services $7.75 General
Category: ONCOLOGY
11/22/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $14.01 General
Category: ONCOLOGY
11/20/2024 Novocure Inc. Optune Lua (NovoTTF-200T) (Device) Food and Beverage Cash or cash equivalent $12.15 General
Category: Oncology
11/12/2024 Blueprint Medicines Corporation AYVAKIT (Drug) Food and Beverage Cash or cash equivalent $14.84 General
Category: Oncology / Rare Diseases
11/08/2024 Cumberland Pharmaceuticals, Inc. SANCUSO (Drug) Food and Beverage In-kind items and services $17.87 General
Category: ONCOLOGY
11/04/2024 Astellas Pharma US Inc Xtandi (Drug) Food and Beverage In-kind items and services $17.38 General
Category: Oncology
11/01/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $17.48 General
Category: Immunology
10/25/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug), Xofigo Food and Beverage In-kind items and services $20.51 General
Category: Oncology
10/22/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), LYNPARZA Food and Beverage In-kind items and services $11.88 General
Category: ONCOLOGY
10/18/2024 PFIZER INC. XTANDI (Drug), ORGOVYX, TALZENNA Food and Beverage In-kind items and services $18.39 General
Category: ONCOLOGY
10/17/2024 PFIZER INC. IBRANCE (Drug), TUKYSA Food and Beverage In-kind items and services $23.71 General
Category: ONCOLOGY
10/08/2024 Tempus AI, Inc Food and Beverage In-kind items and services $28.22 General
10/07/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $22.14 General
Category: ONCOLOGY
10/02/2024 Novartis Pharmaceuticals Corporation SCEMBLIX (Drug) Food and Beverage In-kind items and services $14.22 General
Category: Oncology
10/02/2024 Novartis Pharmaceuticals Corporation SCEMBLIX (Drug) Food and Beverage In-kind items and services $1.34 General
Category: Oncology
09/24/2024 Genentech USA, Inc. Tecentriq (Biological) Food and Beverage In-kind items and services $15.05 General
Category: BioOncology
09/19/2024 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $23.54 General
Category: Hematology/Oncology
09/17/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Food and Beverage In-kind items and services $17.80 General
Category: ONCOLOGY
09/11/2024 Novartis Pharmaceuticals Corporation PLUVICTO (Drug) Food and Beverage In-kind items and services $14.41 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 19 1,072 2,488 $485,836 $199,880
2022 18 1,107 2,602 $481,884 $199,081
2021 19 1,145 2,682 $498,607 $207,910
2020 21 964 2,655 $451,664 $188,205
Total Patients
4,288
Total Services
10,427
Medicare Billing
$795,076
Procedure Codes
79

All Medicare Procedures & Services

79 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
77427 Radiation treatment management, 5 treatment sessions Office 2023 79 248 $87,792 $35,743 40.7%
77014 Ct guidance for insertion of radiation therapy fields Office 2023 97 974 $81,816 $33,388 40.8%
77301 High precision radiation therapy planning Office 2023 79 83 $65,404 $26,362 40.3%
77435 Management of cranial lesion surgery using radiation over multiple sessions Office 2023 38 40 $48,160 $19,762 41.0%
77338 Design and construction of radiation treatment device for high precision radiation therapy Office 2023 79 83 $35,192 $14,428 41.0%
77263 Complex radiation therapy planning Office 2023 110 116 $36,656 $14,116 38.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 62 97 $20,564 $10,583 51.5%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 74 74 $23,902 $9,626 40.3%
77300 Calculation of radiation therapy dose Office 2023 102 312 $19,032 $7,702 40.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 57 77 $11,550 $5,579 48.3%
77334 Design and construction of complex radiation treatment device Office 2023 54 111 $13,542 $5,156 38.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 87 106 $10,388 $4,704 45.3%
77295 3d radiation therapy planning Office 2023 23 25 $10,575 $4,311 40.8%
77293 Obtaining respiratory data needed to develop the optimal radiation treatment Office 2023 28 28 $5,516 $2,267 41.1%
77290 Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved Office 2023 29 31 $4,774 $1,935 40.5%
77470 Special radiation treatment Office 2023 21 21 $4,326 $1,662 38.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 14 14 $3,500 $1,332 38.1%
77280 Obtaining data needed to develop the optimal radiation treatment, 1 treatment area Office 2023 28 37 $2,553 $1,023 40.1%
77332 Design and construction of simple radiation treatment device Office 2023 11 11 $594.00 $202.40 34.1%
77427 Radiation treatment management, 5 treatment sessions Office 2022 83 261 $92,394 $38,085 41.2%
77014 Ct guidance for insertion of radiation therapy fields Office 2022 108 965 $81,060 $32,986 40.7%
77301 High precision radiation therapy planning Office 2022 78 83 $65,404 $26,191 40.0%
77338 Design and construction of radiation treatment device for high precision radiation therapy Office 2022 78 83 $35,192 $14,508 41.2%
77263 Complex radiation therapy planning Office 2022 99 111 $35,076 $13,898 39.6%
77435 Management of cranial lesion surgery using radiation over multiple sessions Office 2022 27 27 $32,508 $13,422 41.3%

About Dr. Ryan Abel, MD

Dr. Ryan Abel, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Owensboro, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2009. The National Provider Identifier (NPI) number assigned to this provider is 1437385770.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Abel, MD has received a total of $4,596 in payments from pharmaceutical and medical device companies, with $1,532 received in 2024. These payments were reported across 256 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($4,415).

As a Medicare-enrolled provider, Abel has provided services to 4,288 Medicare beneficiaries, totaling 10,427 services with total Medicare billing of $795,076. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.

Practice Information

Products in Payments

  • KEYTRUDA (Biological) $374.49
  • TAGRISSO (Drug) $161.02
  • Lenvima (Drug) $137.54
  • LIBTAYO (Biological) $123.12
  • XTANDI (Drug) $120.93
  • ERLEADA (Drug) $113.73
  • Optune (Device) $110.68
  • IBRANCE (Drug) $103.88
  • Enhertu (Drug) $89.10
  • ENHERTU (Drug) $88.38
  • SPACEOAR (Device) $82.56
  • ADCETRIS (Biological) $81.92
  • Oncology (Device) $81.38
  • IMBRUVICA (Drug) $68.19
  • BRUKINSA (Drug) $65.97
  • KISQALI (Drug) $63.45
  • REFLEXION MEDICAL RADIOTHERAPY SYSTEM (Device) $63.44
  • Kyprolis (Drug) $63.00
  • PLUVICTO (Drug) $62.40
  • SCEMBLIX (Drug) $60.47

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Owensboro